| Invasive fungal infection (n = 20) | Without invasive fungal infection (n = 40) | P-value | |
---|---|---|---|---|
Median age at ICU admission | 30 ± 7.9 | 37 ± 11.0 | 0.024 | * |
Gender | ||||
   Male | 12 (60%) | 15 (37.5%) | 0.099 |  |
   Female | 8 (40%) | 25 (62.5%) |  |  |
Early vs. late ICU admission after HSCT (day) | 209 ± 158.2 | 73 ± 56.6 | 0.068 |  |
ICU length of stay (day) | 10.7 ± 7.6 | 12.8 ± 14.5 | 0.533 |  |
Underlying disease | ||||
   ALL | 4 (20%) | 5 (12.5%) |  |  |
   AML | 8 (40%) | 7 (17.5%) |  |  |
   CML | 3 (15%) | 9 (22.5%) |  |  |
   Multiple myeloma | 1 (5%) | 3 (7.5%) |  |  |
   Hodgkin's disease | 2 (10%) | 2 (5%) |  |  |
   Other hematological disease | 2 (10%) | 14 (34.5%) |  |  |
Type of transplantation | ||||
   Allo-PBSCT/Allo-BMT | 13 (65%)/4 (20%) | 24 (60%)/5 (12.5%) |  |  |
   Auto-PBSCT/Auto-BMT | 3 (15%)/0 | 10 (25%)/1 (2.5%) |  |  |
GVHD | 16 (80%) | 15 (37.5%) | 0.003 | ** |
CMV infection | 7 (35%) | 6 (15%) | 0.101 | Â |
Neutropenia | 16(80%) | 32 (80%) | 0.099 | Â |
Concurrent bacteremia | 12 (60%) | 26 (65%) | 0.705 | Â |
High dose corticosteroid | 13 (65%) | 10 (25%) | 0.003 | * |
APACHE II score | 22 ± 5.7 | 27 ± 9.8 | 0.014 | * |
SOFA score | 10.45 ± 2.7 | 13 ± 4.0 | 0.020 | * |
ICU mortality | 17 (85%) | 36 (90%) | 0.676 | Â |